6628.HK · TRANSCENTA-B
Hong Kong · RS rating 3 · As of 2026-10-14
| Price | 0.69 HKD |
|---|---|
| 1-day change | -9.2% |
| RS rating (overall / 1M / 3M / 12M) | 3 / 17 / 5 / 3 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 12 / 12 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +85.1% |
| Market cap (USD) | $44.1M |